#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vitamin B12 deficiency Demyelination Neuroendocrine carcinoma of the skin Trigeminal neuralgia Hypoparathyroidism B-cell small lymphocytic lymphoma recurrent Niemann-Pick disease Anaplastic thyroid cancer Warm autoimmune haemolytic anaemia Antiphospholipid antibodies Chronic graft versus host disease in liver Astrocytoma malignant Squamous cell carcinoma of the hypopharynx Chronic myeloid leukaemia (in remission) Colitis ulcerative More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Life with Disease Mucopolysaccharidosis – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) Glomerulonephritis membranoproliferative Lymphangiosarcoma – Diagnostics Haemophagocytic lymphohistiocytosis – Diagnostics Propionic acidaemia – Basic Information Waldenstrom’s macroglobulinaemia refractory – Life with Disease VEXAS syndrome – Treatment Propionic acidaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ublituximab Inclisiran Sodium L-Arginine Hydrochloride Palmidrol Benztropine Mesylate Ep0042 Relatlimab Sodium Lactate Vaborbactam Lonapegsomatropin Gen1053 Lutikizumab Fluoxetine Hydrochloride FIBRIN Lutetium (177Lu) Oxodotreotide Isosorbide Dinitrate Xanomeline Tartrate Mk-1942 Namodenoson Ponsegromab More therapies…

    Learn about Your Condition

    Pancreatic failure Pneumothorax Ischaemic stroke Neuroblastoma recurrent Epithelioid sarcoma Rectosigmoid cancer Macular telangiectasia Infertility Metastasis Ebola disease Tumour thrombosis Conjunctivitis Breast cancer recurrent Corneal dystrophy Encephalitis Japanese B More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Type 2 diabetes mellitus

  • Study on Using Dapagliflozin, Semaglutide, and Finerenone to Prevent Heart and Kidney Complications in Patients with Type 2 Diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Finerenone
    • Dapagliflozin
    • Semaglutide
    Denmark Spain

  • Study on Dapansutrile for Patients with Type 2 Diabetes Not Well Controlled on Standard Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • Dapansutrile
    Belgium France Germany

  • Study on the Effects of Finerenone and SGLT2 Inhibitors on Heart and Kidney Health in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Finerenone
    Denmark

  • Study on Vitamin D (Colecalciferol) to Increase Free Testosterone in Men with Type 2 Diabetes and Low Testosterone Levels

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Colecalciferol
    Belgium

  • Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetes mellitus
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Pioglitazone
    • Empagliflozin
    • Semaglutide
    Denmark Sweden

  • Study on Sodium Phenylbutyrate for Improving Blood Sugar Control in Type 2 Diabetes Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Sodium Phenylbutyrate
    The Netherlands
Previous Page
1 2 3 4 5 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!